AAAAAA
Results: 1-25/43
Authors:
CAI H
WANG XL
COLAGIURI S
WILCKEN DEL
Citation: H. Cai et al., A COMMON GLU(298)-]ASP (894G-]T) MUTATION AT EXON-7 OF THE ENDOTHELIAL NITRIC-OXIDE SYNTHASE GENE AND VASCULAR COMPLICATIONS IN TYPE-2 DIABETES, Diabetes care, 21(12), 1998, pp. 2195-2196
Authors:
CAI H
WANG XL
COLAGIURI S
WILCKEN DEL
Citation: H. Cai et al., METHIONINE SYNTHASE D919G MUTATION IN TYPE-2 DIABETES AND ITS RELATION TO VASCULAR EVENTS, Diabetes care, 21(10), 1998, pp. 1774-1775
Authors:
WILCKEN DEL
Citation: Del. Wilcken, HOMOCYSTEINE AND VASCULAR-DISEASE, Medical journal of Australia, 168(9), 1998, pp. 431-432
Authors:
LYNCH JF
MARSHALL MD
WANG XL
WILCKEN DEL
Citation: Jf. Lynch et al., APOLIPOPROTEIN SCREENING IN AUSTRALIAN CHILDREN - FEASIBILITY AND THEEFFECT OF AGE, SEX, AND ETHNICITY, Medical journal of Australia, 168(2), 1998, pp. 61-64
Authors:
WILCKEN DEL
LYNCH JF
WANG XL
Citation: Del. Wilcken et al., APOLIPOPROTEIN SCREENING IN AUSTRALIAN CHILDREN - REPLY, Medical journal of Australia, 168(12), 1998, pp. 638-639
Authors:
SHEN YH
WANG XL
WILCKEN DEL
Citation: Yh. Shen et al., NITRIC-OXIDE INDUCES AND INHIBITS APOPTOSIS THROUGH DIFFERENT PATHWAYS, FEBS letters, 433(1-2), 1998, pp. 125-131
Authors:
WANG XL
WILCKEN DEL
Citation: Xl. Wang et Del. Wilcken, COMMENTS ON CIRCULATING TRANSFORMING-GROWTH-FACTOR BETA-1 AND CORONARY-ARTERY DISEASE - REPLY, Cardiovascular Research, 37(3), 1998, pp. 830-830
Authors:
WANG XL
WANG J
MCCREDIE RM
WILCKEN DEL
Citation: Xl. Wang et al., POLYMORPHISMS OF FACTOR-V, FACTOR-VII, AND FIBRINOGEN GENES - RELEVANCE TO SEVERITY OF CORONARY-ARTERY DISEASE, Arteriosclerosis, thrombosis, and vascular biology, 17(2), 1997, pp. 246-251
Authors:
WANG XL
MAHANEY MC
SIM AS
WANG J
WANG J
BLANGERO J
ALMASY L
BADENHOP RB
WILCKEN DEL
Citation: Xl. Wang et al., GENETIC CONTRIBUTION OF THE ENDOTHELIAL CONSTITUTIVE NITRIC-OXIDE SYNTHASE GENE TO PLASMA NITRIC-OXIDE LEVELS, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 3147-3153
Authors:
JAHANFAR S
EDEN JA
NGUYEN T
WANG XL
WILCKEN DEL
Citation: S. Jahanfar et al., A TWIN STUDY OF POLYCYSTIC-OVARY-SYNDROME AND LIPIDS, Gynecological endocrinology, 11(2), 1997, pp. 111-117
Authors:
WANG XL
WANG J
WILCKEN DEL
Citation: Xl. Wang et al., INTERACTIVE EFFECT OF P53 GENE AND CIGARETTE-SMOKING ON CORONARY-ARTERY DISEASE, The FASEB journal, 11(9), 1997, pp. 3363-3363
Authors:
LARON Z
WANG XL
KLINGER B
SILBERGELD A
WILCKEN DEL
Citation: Z. Laron et al., GROWTH-HORMONE INCREASES AND INSULIN-LIKE GROWTH-FACTOR-I DECREASES CIRCULATING LIPOPROTEIN(A), European journal of endocrinology, 136(4), 1997, pp. 377-381
Authors:
WILCKEN DEL
WILCKEN B
Citation: Del. Wilcken et B. Wilcken, THE NATURAL-HISTORY OF VASCULAR-DISEASE IN HOMOCYSTINURIA AND THE EFFECTS OF TREATMENT, Journal of inherited metabolic disease, 20(2), 1997, pp. 295-300
Authors:
WILCKEN DEL
Citation: Del. Wilcken, MTHFR 677C-]T MUTATION, FOLATE INTAKE, NEURAL-TUBE DEFECT, AND RISK OF CARDIOVASCULAR-DISEASE, Lancet, 350(9078), 1997, pp. 603-604
Authors:
WILCKEN DEL
WANG XL
WILCKEN B
Citation: Del. Wilcken et al., METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) MUTATION, HOMOCYST(E)INE,AND CORONARY-ARTERY DISEASE, Circulation, 96(8), 1997, pp. 2738-2740
Authors:
WANG XL
WANG J
WILCKEN DEL
Citation: Xl. Wang et al., INTERACTIVE EFFECT OF THE P53 GENE AND CIGARETTE-SMOKING ON CORONARY-ARTERY DISEASE, Cardiovascular Research, 35(2), 1997, pp. 250-255
Authors:
WANG XL
LIU SX
WILCKEN DEL
Citation: Xl. Wang et al., CIRCULATING TRANSFORMING-GROWTH-FACTOR BETA-1 AND CORONARY-ARTERY DISEASE, Cardiovascular Research, 34(2), 1997, pp. 404-410
Authors:
WILCKEN DEL
WANG XL
SIM AS
MCCREDIE RM
Citation: Del. Wilcken et al., DISTRIBUTION IN HEALTHY AND CORONARY POPULATIONS OF THE METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) C677T MUTATION, Arteriosclerosis, thrombosis, and vascular biology, 16(7), 1996, pp. 878-882
Authors:
WANG XL
MCCREDIE RM
WILCKEN DEL
Citation: Xl. Wang et al., GENOTYPE DISTRIBUTION OF ANGIOTENSIN-CONVERTING ENZYME POLYMORPHISM IN AUSTRALIAN HEALTHY AND CORONARY POPULATIONS AND RELEVANCE TO MYOCARDIAL-INFARCTION AND CORONARY-ARTERY DISEASE, Arteriosclerosis, thrombosis, and vascular biology, 16(1), 1996, pp. 115-119
Authors:
WANG XL
WILCKEN DEL
Citation: Xl. Wang et Del. Wilcken, CARDIOVASCULAR-DISEASE RISK - REPLY, Nature medicine, 2(4), 1996, pp. 366-366
Authors:
WANG XL
SIM AS
BADENHOP RF
MCCREDIE RM
WILCKEN DEL
Citation: Xl. Wang et al., A SMOKING-DEPENDENT RISK OF CORONARY-ARTERY DISEASE-ASSOCIATED WITH APOLYMORPHISM OF THE ENDOTHELIAL NITRIC-OXIDE SYNTHASE GENE, Nature medicine, 2(1), 1996, pp. 41-45
Authors:
WANG XL
BADENHOP R
HUMPHREY KE
WILCKEN DEL
Citation: Xl. Wang et al., NEW MSPI POLYMORPHISM AT - ASSOCIATION WITH INCREASED CIRCULATING HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS(83 BP OF THE HUMAN APOLIPOPROTEIN AI GENE ), Genetic epidemiology, 13(1), 1996, pp. 1-10
GROWTH-HORMONE TREATMENT INCREASES CIRCULATING LIPOPROTEIN(A) IN CHILDREN WITH CHRONIC-RENAL-FAILURE
Authors:
LARON Z
WANG XL
KLINGER B
SILBERGELD A
DAVIDOVITS M
EISENSTEIN B
WILCKEN DEL
Citation: Z. Laron et al., GROWTH-HORMONE TREATMENT INCREASES CIRCULATING LIPOPROTEIN(A) IN CHILDREN WITH CHRONIC-RENAL-FAILURE, Journal of pediatric endocrinology & metabolism, 9(5), 1996, pp. 533-537
Authors:
WILCKEN DEL
WANG XL
Citation: Del. Wilcken et Xl. Wang, RELEVANCE TO SPINA-BIFIDA OF MUTATED METHYLENETETRAHYDROFOLATE REDUCTASE, Lancet, 347(8997), 1996, pp. 340-340
Authors:
LARON Z
WANG XL
KLINGER B
SILBERGELD A
WILCKEN DEL
Citation: Z. Laron et al., INSULIN-LIKE GROWTH-FACTOR-I DECREASES SERUM LIPOPROTEIN(A) DURING LONG-TERM TREATMENT OF PATIENTS WITH LARON SYNDROME, Metabolism, clinical and experimental, 45(10), 1996, pp. 1263-1266